International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889492) titled 'A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Edesa Biotech Inc.

Condition: Non-Segmental Vitiligo (NSV)

Intervention: Other: Placebo IV

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: September 2026

Target Sample Size: 80

Countries of Recruitment: Canad...